4//SEC Filing
Lowdell Mark William 4
Accession 0001213900-22-014509
CIK 0001711754other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:35 PM ET
Size
7.3 KB
Accession
0001213900-22-014509
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Lowdell Mark William
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-03-22$8.43/sh+23,590$198,864→ 1,496,383 total - Award
Option (right to buy)
2022-03-21+104,000→ 104,000 totalExercise: $7.92Exp: 2032-03-20→ Common Stock (104,000 underlying)
Footnotes (2)
- [F1]The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities. These shares were purchased by the Reporting Person directly from Issuer.
- [F2]Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767037
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 4:35 PM ET
- Size
- 7.3 KB